Nonpeptidic glucagon-like peptide 1 receptor agonists: A magic bullet for diabetes
Our licensed clinical team will guide you through dosage options, infusion timing, and what to expect before, during, and after treatment so you can choose the option that best fits your goals and schedule
Takahashi C, Sasaki N, Kitajima S
Its better to keep building on your momentum and strengthening your healthy habits, so you can maintain these over the years to come
Building upon these insights, novel therapeutic strategies are being developed that leverage pharmacogenomic information (e.g., PNPLA3 I148M-guided therapy) and microbiome-based interventions
Am J Resp Crit Care Med 2010;182:47788